Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-029195
Filing Date
2023-03-07
Accepted
2023-03-06 19:39:19
Documents
8
Effectiveness Date
2023-03-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm238542d1_s8.htm S-8 112884
2 EXHIBIT 5.1 tm238542d1_ex5-1.htm EX-5.1 15741
3 EXHIBIT 23.1 tm238542d1_ex23-1.htm EX-23.1 2115
4 EXHIBIT 99.3 tm238542d1_ex99-3.htm EX-99.3 194541
5 EX-FILING FEES tm238542d1_ex-filingfees.htm EX-FILING FEES 17735
6 GRAPHIC tm238542d1_s8img001.jpg GRAPHIC 3582
7 GRAPHIC tm238542d1_ex5-1img002.jpg GRAPHIC 4246
8 GRAPHIC tm238542d1_ex5-1img001.jpg GRAPHIC 2797
  Complete submission text file 0001104659-23-029195.txt   359185
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270314 | Film No.: 23710628
SIC: 2834 Pharmaceutical Preparations